Triazole compounds that modulate HSP90 activity

Details for Australian Patent Application No. 2007284537 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Foley, Kevin; Ying, Weiwen

Agent Davies Collison Cave

Pub. Number AU-B-2007284537

PCT Pub. Number WO2008/021364

Priority 60/838,306 17.08.06 US

Filing date 14 August 2007

Wipo publication date 21 February 2008

Acceptance publication date 12 April 2012

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/52 (2006.01)

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/021364 Priority application(s): WO2008/021364

12 April 2012 Application Accepted

  Published as AU-B-2007284537

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007284542-Tricyclic compounds and its use as tyrosine kinase modulators

2007284532-Measurement of autonomic function